Explore peer-reviewed studies, experimental findings, and cutting-edge developments across nanomaterials, nanomedicine, and nanoengineering.
Revolutionary favipiravir-tocilizumab nanovesicles deliver targeted COVID-19 treatment directly to lungs with 35x greater efficacy than conventional methods.